Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9) Peptide
CHRNA9
Reactivity: Human
Host: Synthetic
WB
-
- Target See all CHRNA9 products
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
- Origin
- Human
-
Source
- Synthetic
- Application
- Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ACHA9 antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
- Synonyms
- HSA243342 Peptide, NACHRA9 Peptide, 2410015I05Rik Peptide, Acra9 Peptide, EG666827 Peptide, Gm8311 Peptide, cholinergic receptor nicotinic alpha 9 subunit Peptide, cholinergic receptor, nicotinic, alpha polypeptide 9 Peptide, CHRNA9 Peptide, Chrna9 Peptide
- Background
-
This gene is a member of the ligand-gated ionic channel family and nicotinic acetylcholine receptor gene superfamily. It encodes a plasma membrane protein that forms homo- or hetero-oligomeric divalent cation channels. This protein is involved in cochlea hair cell development and is also expressed in the outer hair cells (OHCs) of the adult cochlea.
Alias Symbols: NACHRA9
Protein Size: 479 - Molecular Weight
- 52 kDa
- Gene ID
- 55584
- NCBI Accession
- NP_060051
- UniProt
- Q9UGM1
-
You are here:
